Move your pointer across the image to compare. On touch screens, tap the image or drag the divider. Use the arrow keys when the comparison control is focused.
Age at onset remains the strongest predictor of disease course and life expectancy. More severe NPC1 mutations cause earlier neurological onset, faster cholesterol accumulation, and more rapid progression. Infantile-onset NPC, with age of neurological onset before the age of 6, accounts for about half of all NPC diagnoses.
I-NPC follows a stepwise downward course: developmental delay or loss of skills in the first years, progressive ataxia, slurred speech, swallowing difficulty in early-to-mid childhood, and a late phase of severe dystonia, swallowing failure, seizures, and loss of mobility. Once neurological symptoms appear, the disease does not stabilize or reverse.
Adrabetadex reaches the lysosome, where cholesterol is trapped in Niemann-Pick disease type C, reversibly binds that accumulated cholesterol and transfers it to the lysosomal membrane, from which the cell’s own machinery can move it to where it is needed. No approved medicine acts directly on the cholesterol that accumulates inside cells, leaving diseases of cholesterol trafficking without treatments aimed at the biology driving them.
About NPC
- Niemann-Pick disease, type C (NPC) is a rare, inherited disorder caused by pathogenic variants in the NPC1 or NPC2 genes.
- Accumulation of cholesterol in the lysosomes impacts cellular function, affecting every cell in the body.
- This disruption of cholesterol trafficking is most devastating in the brain and nervous system, driving progressive neurological decline and increased cell death in multiple organs and tissues.
- Infantile onset NPC is the most aggressive form of the disease, with neurological symptom onset before the age of 6.
- Disease presentation is heterogeneous and frequently missed during early stages where intervention can have the biggest impact.n.
Learn more about symptoms, diagnostic testing: